Epizyme
Get Full AccessDescription
- Epizyme, Inc. is a clinical stage biopharmaceutical company creating epigenetic therapeutics for patients with cancer. Epizyme has built a proprietary product platform that the company uses to create small molecule inhibitors of a 96-member class of enzymes known as histone methyltransferases, or HMTs. HMTs are part of the system of gene regulation, referred to as epigenetics, that controls gene expression. Genetic alterations can result in changes to the activity of HMTs, making them oncogenic (cancer-causing). By focusing on the genetic drivers of cancers, Epizyme's targeted science seeks to match the right medicines with the right patients for a personalized approach to cancer treatment. Epizyme has two programs in clinical development. Our lead program, EPZ-6438, is in Phase 1/2 development for Non-Hodgkin Lymphoma and a subset of genetically defined tumors including malignant rhabdoid tumors, epithelioid sarcomas, and synovial sarcomas. Epizyme owns worldwide rights to EPZ-6438 outside of Japan, and pl
-
Headquarters:400 Technology Square , Cambridge, Massachusetts, United States
More -
Phone Number: +1 617-229-5872
-
Website: https://www.epizyme.com
-
Employees:289
-
Revenue:$250 - 500M
-
Legal Name:Epizyme
-
Epizyme's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Epizyme
-
Where are Epizyme's Headquarters?
Epizyme's Headquarters are in 400 Technology Square ,Cambridge,Massachusetts,United States
-
What is Epizyme's phone number?
Epizyme's phone number is +1 617-229-5872
-
What is Epizyme's official website?
Epizyme's official website is https://www.epizyme.com
-
What is Epizyme's Revenue?
Epizyme's revenue is $250 - 500M
-
What is Epizyme's NAICS code?
Epizyme's NAICS code is 541713
-
How many employees are working in Epizyme
Epizyme has 289 employees
-
What is Epizyme's Industry?
Epizyme is in the industry of Biotechnology
-
Who is Epizyme's CEO?
Epizyme's CEO is Grant Bogle

